Soul of Healing Inc to provide treatments to patients in China

Recent developments have been rapid for Soul of Healing a US based nonprofit with its subsidiary in India.

A recent partnership with Dr. Cheng from Beijing will have video technology used to identify and prescribe generic treatments to Chinese patients.

Resof-L will be given out to patients suffering from genotype 1.

The generic combination of Sofosbuvir 400mg and Ledipasvir 90mg has been highly effective.

We hope to reach out to many more patients from China with the help of Dr. Cheng.

This definitely would be a start in the nonprofits initiative helping the People's Republic of China to eradicate Hep C for good. 

The dilemma behind generic branding in the Indian Pharmaceutical Market! '

It is important to note that Gilead has licensed over 11 pharmaceutical companies to produce generic hepatitis c medication.

The generics made have molecular similarities with Gilead's brand of medications namely Harvoni, Sovaldi and Epclusa.

Both Harvoni and generic Harvoni Resof-L have molecular similarities to treat effectively genotypes 1,4 and 5 with the combination of Ledipasvir 90mg and Sofosbuvir 400mg.

Both Sovaldi and generic Sovaldi Resof have molecular similarities to effectively treat genotypes 2, 3 and 6 with Sofosbuvir 400mg.

In India there are different brands that are produced but are manufactured by two labs, Hetero Labs and Natco.

Generic brands that have similar contents to Gileads harvoni go by the name Resof L, Hepcivir-l, Hepcinat-lp, MyHep-LVIR.

Generic brands that have similar contents to Gileads Sovaldi go by the name Resof, Hepcivir,

The prices for the international market vary from the distributors to fluctuations in the pharmaceutical market.

There are 12 million people suffering from Hepatitis C in India.

For more information click here.